Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 1.00 |
| ▸ | PPARG | P37231 | 6/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 4/20 | 1.00 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 1.00 |
| ▸ | RXRA | P19793 | 2/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.77 |
| ▸ | F7 | P08709 | 4/20 | 0.77 |
| ▸ | F3 | P13726 | 4/20 | 0.77 |
| ▸ | PPARD | Q03181 | 4/20 | 0.77 |
| ▸ | PPARA | Q07869 | 4/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.77 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.77 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.71 |
| ▸ | HPGD | P15428 | 2/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Doconexent SCHEMBL18274946 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL2241832 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185529 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185428 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL17289459 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185531 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL13900774 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185505 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL12073579 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL6473094 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119564656-A | Anti-inflammatory substance and use thereof | 中国科学院动物研究所 | 2025-03-07 | — | — | CN | disclosed |
| US-11856952-B2 | Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil | NIPPON SUISAN KAISHA, LTD. (JP) | 2024-01-02 | — | — | US | disclosed |
| EP-2771696-B1 | METHODS MAKING USE OF PANELS OF METABOLITES FOR THE DIAGNOSIS AND DIFFERENTIATION OF NEONATAL ENCEPHALOPATHY | INFANDX AG (DE) | 2022-09-14 | — | — | EP | disclosed |
| US-20220248671-A1 | MICROBIAL OIL, PRODUCTION METHOD FOR MICROBIAL OIL, CONCENTRATED MICROBIAL OIL, AND PRODUCTION METHOD FOR CONCENTRATED MICROBIAL OIL | NIPPON SUISAN KAISHA, LTD. (JP) | 2022-08-11 | — | — | US | disclosed |
| US-11313866-B2 | Method of diagnosing and treating asphyxia | INFANDX AG (DE) | 2022-04-26 | — | — | US | disclosed |
| US-11253468-B2 | Organic toothpaste | RADIUS CORPORATION (US) | 2022-02-22 | — | — | US | disclosed |
| EP-3900543-A1 | MICROBIAL OIL, PRODUCTION METHOD FOR MICROBIAL OIL, CONCENTRATED MICROBIAL OIL, AND PRODUCTION METHOD FOR CONCENTRATED MICROBIAL OIL | NIPPON SUISAN KAISHA, LTD. (JP) | 2021-10-27 | — | — | EP | disclosed |
| US-11090330-B2 | Pharmaceutical solution having a toxicity-reducing effect for antitumor drugs, and pharmaceutical composition comprising same | CHEN SONGYUAN (CN) | 2021-08-17 | — | — | US | disclosed |
| CN-110200906-B | L-menthol aqueous solution and preparation method thereof | 奥纳斯(北京)医药科技有限公司 | 2021-07-20 | — | — | CN | disclosed |
| CN-112245327-B | Antibacterial composition, mouthwash and preparation method of mouthwash | 苏州承芃和医药科技有限公司 | 2021-06-22 | — | — | CN | disclosed |
| US-20140308687-A1 | Method and Use of Metabolites for the Diagnosis and Differentiation of Neonatal Encephalopathy | INFANDX AG (DE) | 2014-10-16 | — | — | US | disclosed |
| US-20130158070-A1 | CONJUGATES OF POLYUNSATURATED FATTY ACIDS AND AMINE-CONTAINING COMPOUNDS AND USES THEREOF | MEDWELL LABORATORIES LTD. (IL) | 2013-06-20 | — | — | US | disclosed |
| US-20130158070-A1 | CONJUGATES OF POLYUNSATURATED FATTY ACIDS AND AMINE-CONTAINING COMPOUNDS AND USES THEREOF | MEDWELL LABORATORIES LTD. (IL) | 2013-06-20 | — | — | US | disclosed |
| US-20120208282-A1 | Method For Normalization in Metabolomics Analysis Methods with Endogenous Reference Metabolites. | BIOCRATES LIFE SCIENCES AG | 2012-08-16 | — | — | US | disclosed |
| US-20120136581-A1 | Method of Diagnosing Asphyxia | BIOCRATES LIFE SCIENCES AG (AT) | 2012-05-31 | — | — | US | disclosed |
| EP-2449488-A1 | METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES | BIOCRATES Life Sciences AG (AT) | 2012-05-09 | — | — | EP | disclosed |
| EP-2427773-A1 | METHOD OF DIAGNOSING ASPHYXIA | Keller, Matthias (DE) | 2012-03-14 | — | — | EP | disclosed |
| WO-2011000753-A1 | METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES | BIOCRATES LIFE SCIENCES AG (AT) | 2011-01-06 | — | — | WO | disclosed |
| EP-2270699-A1 | Method for normalization in metabolomics analysis methods with endogenous reference metabolites | BIOCRATES Life Sciences AG (AT) | 2011-01-05 | — | — | EP | disclosed |
| WO-2010128054-A1 | METHOD OF DIAGNOSING ASPHYXIA | BIOCRATES LIFE SCIENCES AG (AT) | 2010-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130158070-A1 | CONJUGATES OF POLYUNSATURATED FATTY ACIDS AND AMINE-CONTAINING COMPOUNDS AND USES THEREOF | ALOX5, ALOX15B, ALOX15 | ALDH1A1 241/4885PPARG 587/4885CYP19A1 229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.